A Study to Evaluate the Safety, Tolerability and Efficacy of AIN457 in Patients With Relapsing-remitting Multiple Sclerosis ClinicalTrials.gov, 9 May 2013 Accessed on 28 Oct 2013 from http://www.clinicaltrials.gov/ct2/show/NCT01433250. CommentRecommendBookmarkWatch